Antonio Tapia-Galisteo

5PUBLICATIONS
59CO-AUTHORS
Medical devicesTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 24, 2026
A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

|Apr 16, 2024
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.

Antonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Apr 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood

|Feb 14, 2022
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

Antonio Tapia-Galisteo, Íñigo Sánchez Rodríguez, Oscar Aguilar-Sopeña

Pageof 1